Identification and characterization of a human antibody profile inversely associated with adverse cardiovascular events
- 1University of Kentucky
Abstract
Objective: The immune response is linked to the progression of atherosclerotic cardiovascular disease (CVD). We sought to characterize a predictive cardiovascular antibody biomarker using two independent cohorts. Approach and Results: A human IgG profile serendipitously identified by ELISA was quantified in a well characterized cohort of 359 patients with a history of coronary artery disease (CAD) who experienced a total of 71 incident adverse CVD events (death, myocardial infarction, and stroke) over a median 4.1-year follow-up. Using Cox proportional hazard regression analysis, low biomarker levels were an independent predictor of adverse cardiovascular outcomes after adjustment for age, sex, diabetes mellitus, estimated glomerular filtration rate, presence of obstructive CAD, heart failure, total cholesterol, and high-density lipoprotein (HDL) cholesterol (adjusted hazard ratio of 1.90 [95% CI: 1.03 to 3.49; p=0.038] between lowest and highest tertiles). Validation was then performed in a larger secondary cohort using 4356 baseline samples from the Multi-Ethnic Study of Atherosclerosis (MESA), a prospective study of cardiovascular outcomes resulting in adjusted odds ratio of 50.5 per unit decrease in log-transformed biomarker [95% CI: 2.4 to 2773.1; p=0.030] over one year by logistic regression analysis. Conclusions: Low levels of human IgG antibodies targeting Bovidae IgG are independently associated with increased incidence of CVD events in patients with or without a history of CAD, indicating the potential clinical predictive power of this antibody profile as an inverse biomarker for CVD.
Related
- Identification of Cryptococcus neoformans capsule-associated protein antigens that mediate B cell-dependent vaccine protection in mice and elicit antibody responses in humans with cryptococcosis
- Identification, Isolation and Genomic Characterization of an Emerging Shamonda Virus Variant Associated with Bovine Disease in Switzerland.
- Genome-Wide Identification and Functional Characterization of the TIFY Gene Family Associated with Abiotic Stress and Hormone Response in Carthamus tinctorius L.
- Identification of a pan-orthoebolavirus-reactive antibody from an rVSV-EBOV vaccinated individual
- Identification and characterization of two transmembrane proteins required for virulence of Ustilago maydis
BibTeX
@misc{henson2026identification,
title = {{Identification and characterization of a human antibody profile inversely associated with adverse cardiovascular events}},
author = {D. Henson and K. L. Thompson and A. Samman Tahhan and R. Marion and T. Azawi and P. Yeh and G. S. Hawk and A. P. DeFilippis and A. A. Quyyumi and V. J. Venditto},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.01.748614},
url = {https://www.biorxiv.org/content/10.64898/2026.09.01.748614v1},
note = {CC BY-NC},
}
RIS
TY - UNPB
TI - Identification and characterization of a human antibody profile inversely associated with adverse cardiovascular events
AU - D. Henson
AU - K. L. Thompson
AU - A. Samman Tahhan
AU - R. Marion
AU - T. Azawi
AU - P. Yeh
AU - G. S. Hawk
AU - A. P. DeFilippis
AU - A. A. Quyyumi
AU - V. J. Venditto
PY - 2026
DA - 2026/09/01
PB - bioRxiv
DO - 10.64898/2026.09.01.748614
UR - https://www.biorxiv.org/content/10.64898/2026.09.01.748614v1
AB - Objective: The immune response is linked to the progression of atherosclerotic cardiovascular disease (CVD). We sought to characterize a predictive cardiovascular antibody biomarker using two independent cohorts. Approach and Results: A human IgG profile serendipitously identified by ELISA was quantified in a well characterized cohort of 359 patients with a history of coronary artery disease (CAD) who experienced a total of 71 incident adverse CVD events (death, myocardial infarction, and stroke) over a median 4.1-year follow-up. Using Cox proportional hazard regression analysis, low biomarker levels were an independent predictor of adverse cardiovascular outcomes after adjustment for age, sex, diabetes mellitus, estimated glomerular filtration rate, presence of obstructive CAD, heart failure, total cholesterol, and high-density lipoprotein (HDL) cholesterol (adjusted hazard ratio of 1.90 [95% CI: 1.03 to 3.49; p=0.038] between lowest and highest tertiles). Validation was then performed in a larger secondary cohort using 4356 baseline samples from the Multi-Ethnic Study of Atherosclerosis (MESA), a prospective study of cardiovascular outcomes resulting in adjusted odds ratio of 50.5 per unit decrease in log-transformed biomarker [95% CI: 2.4 to 2773.1; p=0.030] over one year by logistic regression analysis. Conclusions: Low levels of human IgG antibodies targeting Bovidae IgG are independently associated with increased incidence of CVD events in patients with or without a history of CAD, indicating the potential clinical predictive power of this antibody profile as an inverse biomarker for CVD.
ER -